World Wires · story 78720 · corroborated · 1 source(s)

Bayer shares rise following China approval for stroke drug

China's National Medical Products Administration approved Bayer's anticoagulant drug Asundexian, marketed as Sunharbo, boosting the German firm's pharmaceu

Open in the desk

Coverage

• Bayer shares rise following China approval for stroke drug El País América · tier B · clear net · 2026-10-26 11:27 UTC

What this site indexes